ArticleJournal of experimental & clinical cancer research : CR2024

Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer.

Weisong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.